Drägerwerk AG & Co. KGaA · ISIN: DE0005550602 · EQS - Company News

Changes in the chair of the Dräger Supervisory Board

Changes in the chair of the Dräger Supervisory Board Lübeck – Stefan Lauer, currently Chairman of all Dräger Supervisory Boards, has decided to step down as Chairman at the end of the year for health reasons. The Supervisory Board committees approved this move at their meetings today and passed the following resolutions: From January 1, 2025, the chair of the Supervisory Board of Drägerwerk AG & Co. KGaA will be taken over by Maria Dietz, who has been a member of the Supervisory Board sinc...

XETR:DRW8 Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Drägerwerk AG & Co. KGaA

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (2)
Short Selling (DE) (8)
Short Selling (UK) (0)
11 December 2024 02:06PM
Changes in the chair of the Dräger Supervisory Board
DE0005550602
Changes in the chair of the Dräger Supervisory Board Lübeck – Stefan Lauer, currently Chairman of all Dräger Supervisory Boards, has decided to step down as Chairman at the end of the year for health reasons. The Supervisory Board committees approved this move at their meetings today and passed the following resolutions: From January 1, 2025, the...
Drägerwerk AG & Co. KGaA
About the publication
22 November 2024 02:01PM
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
DE0005550602
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission: Extension of the share buyback for the employee stock program On September 2, 2024, the Executive Board of Drägerwerk Verwaltungs AG had resolved a share buyback for the employee stock program of Dräge...
Drägerwerk AG & Co. KGaA
About the publication
29 October 2024 07:30AM
Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024
DE0005550602
Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024 Order intake exceeds high prior-year level Net sales almost reach the strong prior-year figure EBIT up around four percent Annual forecast confirmed Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first nine months ...
Drägerwerk AG & Co. KGaA
About the publication
16 October 2024 07:00AM
Dräger with good demand in the first nine months of 2024
DE0005550602
Dräger with good demand in the first nine months of 2024 Order intake exceeds the high prior-year level Net sales almost reach the strong prior-year figure EBIT up around four percent Annual forecast confirmed Lübeck – Dräger's preliminary order intake rose by 1.4 percent (net of currency effects; nominal: 0.7 percent) to around EUR 2,421 milli...
Drägerwerk AG & Co. KGaA
About the publication
01 October 2024 09:35AM
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
DE0005550602
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission On September 2, 2024, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back some...
Drägerwerk AG & Co. KGaA
About the publication
25 July 2024 07:30AM
Dräger on track to meet annual forecast after a solid first half-year
DE0005550602
Dräger on track to meet annual forecast after a solid first half-year Order intake slightly above the high prior-year level Net sales still slightly down so far EBIT around 17 percent above the prior-year figure Annual forecast confirmed Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first half of 2024 thanks to good ov...
Drägerwerk AG & Co. KGaA
About the publication
12 July 2024 06:47PM
Preliminary figures H1 2024: Earnings above prior year
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures H1 2024: Earnings above prior year Lübeck, July 12, 2024 – Dräger's earnings in the first half of the year were up on the prior-year figure despite a slight decline in net sales. Net sales and earnings in the first quarter were still lower ...
Drägerwerk AG & Co. KGaA
About the publication
08 May 2024 04:45PM
Dräger makes sustainability and quality an Executive Board responsibility
DE0005550602
Dräger makes sustainability and quality an Executive Board responsibility Stefanie Hirsch will be appointed to the Executive Board as of July 1, 2024 Dräger is creating a new, additional Executive Board position for sustainability and quality. At its meeting today, the Supervisory Board of Drägerwerk Verwaltungs AG decided to appoint Stefanie Hir...
Drägerwerk AG & Co. KGaA
About the publication
08 May 2024 03:33PM
Dräger annual shareholders’ meeting approves significant dividend increase
DE0005550602
Dräger annual shareholders’ meeting approves significant dividend increase Lübeck – Drägerwerk AG & Co. KGaA held its Annual Shareholders’ Meeting 2024 today. All resolutions on the agenda items were passed with a vast majority. In total, 46.2 percent of the share capital was represented (2023: 45.7 percent). Dividend Among the agenda items w...
Drägerwerk AG & Co. KGaA
About the publication
08 May 2024 03:33PM
Dräger annual shareholders’ meeting approves significant dividend increase
DE0005550602
Dräger annual shareholders’ meeting approves significant dividend increase Lübeck – Drägerwerk AG & Co. KGaA held its Annual Shareholders’ Meeting 2024 today. All resolutions on the agenda items were passed with a vast majority. In total, 46.2 percent of the share capital was represented (2023: 45.7 percent). Dividend Among the agenda items w...
Drägerwerk AG & Co. KGaA
About the publication
25 April 2024 07:30AM
Dräger with solid business performance in the first quarter of 2024
DE0005550602
Dräger with solid business performance in the first quarter of 2024 Order intake slightly above high prior-year level Net sales and earnings below strong prior-year quarter due to base effects Annual forecast confirmed Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first quarter of 2024 thanks to good overall demand. At ...
Drägerwerk AG & Co. KGaA
About the publication
15 April 2024 07:14PM
Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed Lübeck, April 15, 2024 – In the first quarter, which is traditionally weak for Dräger, the Company once again achieved a positive operating resu...
Drägerwerk AG & Co. KGaA
About the publication
07 March 2024 07:30AM
Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
DE0005550602
Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend Order intake (net of currency effects) slightly above the high prior-year level Net sales increase by around 13 percent (net of currency effects) compared to the prior year Both divisions and all regions contribute to net sales growth ...
Drägerwerk AG & Co. KGaA
About the publication
15 January 2024 06:48PM
Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024 Lübeck, January 15, 2024 – Dräger's net sales and earnings increased significantly in fiscal year 2023 based on preliminary calculations. This w...
Drägerwerk AG & Co. KGaA
About the publication
13 December 2023 06:41PM
Annual forecast raised again
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Annual forecast raised again Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and ef...
Drägerwerk AG & Co. KGaA
About the publication
13 December 2023 05:12PM
Annual forecast raised again
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Annual forecast raised again Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and ef...
Drägerwerk AG & Co. KGaA
About the publication
20 November 2023 12:18PM
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DE0005550602
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052: Purchase of own shares – final notice In the period from 4 October 2023 to 17 November 2023 (inclusive), a total of 80,460 preferred shares were bought back within the framework of the share buyback of D...
Drägerwerk AG & Co. KGaA
About the publication
02 November 2023 07:30AM
Dräger significantly increases net sales and earnings in the first nine months of 2023
DE0005550602
Dräger significantly increases net sales and earnings in the first nine months of 2023 Order intake (net of currency effects) slightly above the high prior-year level Net sales increase by around 17 percent (net of currency effects) compared to the prior-year period Both divisions and all regions contribute to net sales growth Noticeable improv...
Drägerwerk AG & Co. KGaA
About the publication
16 October 2023 07:48PM
Significant increase in earnings – full-year forecast raised
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised Lübeck, October 16, 2023 – Dräger's net sales and earnings increased significantly in the third quarter of 2023 based on preliminary calculations. This was due in particu...
Drägerwerk AG & Co. KGaA
About the publication
02 October 2023 06:00PM
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
DE0005550602
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission On September 11, 2023, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back som...
Drägerwerk AG & Co. KGaA
About the publication
27 July 2023 07:30AM
Drägerwerk AG & Co. KGaA: Dräger with significant increase in net sales and earnings in the first half of 2023
DE0005550602
Dräger with significant increase in net sales and earnings in the first half of 2023 Net sales increase of around 20 percent compared to the prior-year period Noticeable improvement in delivery capabilities Net sales growth across both segments and all regions EBIT well up at around EUR 48 million Order intake slightly below high prior-year le...
Drägerwerk AG & Co. KGaA
About the publication
27 July 2023 07:30AM
Dräger with significant increase in net sales and earnings in the first half of 2023
DE0005550602
Dräger with significant increase in net sales and earnings in the first half of 2023 Net sales increase of around 20 percent compared to the prior-year period Noticeable improvement in delivery capabilities Net sales growth across both segments and all regions EBIT well up at around EUR 48 million Order intake slightly below high prior-year le...
Drägerwerk AG & Co. KGaA
About the publication
14 July 2023 06:29PM
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed Lübeck, July 14, 2023 – Dräger's net sales in the first half of 2023 increased by 19.6 percent (net of currency effects; nominal: 17.7 percent) t...
Drägerwerk AG & Co. KGaA
About the publication
14 July 2023 06:29PM
Net sales and earnings significantly above prior year – full-year guidance reaffirmed
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed Lübeck, July 14, 2023 – Dräger's net sales in the first half of 2023 increased by 19.6 percent (net of currency effects; nominal: 17.7 percent) t...
Drägerwerk AG & Co. KGaA
About the publication
05 May 2023 04:18PM
Drägerwerk AG & Co. KGaA: Correction of a prior-year figure in the ad-hoc notification dated April 17, 2023. All other content unchanged.
DE0005550602
Due to an editorial error, the German version of the ad-hoc notification dated April 17, 2023 on the preliminary financial figures for the first quarter 2023 incorrectly stated the Group order intake for the prior-year quarter in "Mrd." (billion) instead of "Mio." (million): Order intake "3 Monate 2022" (3 months 2022) was erroneously stated as "82...
Drägerwerk AG & Co. KGaA
About the publication
05 May 2023 04:18PM
Correction of a prior-year figure in the ad-hoc notification dated April 17, 2023. All other content unchanged.
DE0005550602
Due to an editorial error, the German version of the ad-hoc notification dated April 17, 2023 on the preliminary financial figures for the first quarter 2023 incorrectly stated the Group order intake for the prior-year quarter in "Mrd." (billion) instead of "Mio." (million): Order intake "3 Monate 2022" (3 months 2022) was erroneously stated as "82...
Drägerwerk AG & Co. KGaA
About the publication
05 May 2023 04:07PM
Drägerwerk AG & Co. KGaA: Dräger's Annual General Meeting approves stable dividend for fiscal year 2022
DE0005550602
Dräger's Annual General Meeting approves stable dividend for fiscal year 2022 Lübeck—Drägerwerk AG & Co. KGaA held its Annual General Meeting 2023 today. All resolutions on the agenda items were passed with a vast majority. In total, 45.7 percent of the share capital was represented (2022: 46.5 percent). Dividend Among the agenda items was th...
Drägerwerk AG & Co. KGaA
About the publication
05 May 2023 04:07PM
Dräger's Annual General Meeting approves stable dividend for fiscal year 2022
DE0005550602
Dräger's Annual General Meeting approves stable dividend for fiscal year 2022 Lübeck—Drägerwerk AG & Co. KGaA held its Annual General Meeting 2023 today. All resolutions on the agenda items were passed with a vast majority. In total, 45.7 percent of the share capital was represented (2022: 46.5 percent). Dividend Among the agenda items was th...
Drägerwerk AG & Co. KGaA
About the publication
28 April 2023 07:30AM
Dräger with strong net sales growth and positive earnings in the first quarter of 2023
DE0005550602
Dräger with strong net sales growth and positive earnings in the first quarter of 2023 Net sales increase of 18 percent compared to the same quarter in the previous year Net sales growth across both divisions and all regions EBIT well up at around EUR 29 million Noticeable improvement in supply capability as well as temporarily high demand for ...
Drägerwerk AG & Co. KGaA
About the publication
28 April 2023 07:30AM
Drägerwerk AG & Co. KGaA: Dräger with strong net sales growth and positive earnings in the first quarter of 2023
DE0005550602
Dräger with strong net sales growth and positive earnings in the first quarter of 2023 Net sales increase of 18 percent compared to the same quarter in the previous year Net sales growth across both divisions and all regions EBIT well up at around EUR 29 million Noticeable improvement in supply capability as well as temporarily high demand for ...
Drägerwerk AG & Co. KGaA
About the publication
17 April 2023 05:49PM
Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed Lübeck, April 17, 2023 – Dräger's net sales in the first quarter of 2023 increased by 18.0 percent (net of currency effects) to around EUR 761 million, thus si...
Drägerwerk AG & Co. KGaA
About the publication
17 April 2023 05:49PM
Strong net sales growth and positive EBIT – forecast for 2023 confirmed
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed Lübeck, April 17, 2023 – Dräger's net sales in the first quarter of 2023 increased by 18.0 percent (net of currency effects) to around EUR 761 million, thus si...
Drägerwerk AG & Co. KGaA
About the publication
09 March 2023 07:30AM
Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
DE0005550602
Dräger expects return to profitable growth in 2023 Order intake up in fiscal year 2022 despite difficult conditions Net sales and earnings significantly below prior year, in particular due to disrupted supply chains Significant increase in net sales and earnings as well as partial improvement in delivery capability in the fourth quarter of 2022 ...
Drägerwerk AG & Co. KGaA
About the publication
09 March 2023 07:30AM
Dräger expects return to profitable growth in 2023
DE0005550602
Dräger expects return to profitable growth in 2023 Order intake up in fiscal year 2022 despite difficult conditions Net sales and earnings significantly below prior year, in particular due to disrupted supply chains Significant increase in net sales and earnings as well as partial improvement in delivery capability in the fourth quarter of 2022 ...
Drägerwerk AG & Co. KGaA
About the publication
17 January 2023 04:07PM
return to growth and profitability
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability Lübeck, January 17, 2023 – Despite good overall demand for our products and services, Dräge...
Drägerwerk AG & Co. KGaA
About the publication
03 January 2023 09:27AM
Dräger redeems last participation certificates – streamlining of capital structure completed
DE0005550602
Dräger redeems last participation certificates – streamlining of capital structure completed Lübeck—Yesterday, Drägerwerk AG & Co. KGaA redeemed all 382,289 remaining series D profit participation certificates as planned in return for a payment of EUR 546.20 per participation certificate. This completes the redemption of all outstanding partic...
Drägerwerk AG & Co. KGaA
About the publication
28 November 2022 02:34PM
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DE0005550602
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052 Purchase of own shares – final notice In the period from 5 October 2022 to 25 November 2022 (inclusive), a total of 108,896 preferred shares were bought back within the framework of the share buyback of ...
Drägerwerk AG & Co. KGaA
About the publication
28 November 2022 02:34PM
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DE0005550602
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052 Purchase of own shares – final notice In the period from 5 October 2022 to 25 November 2022 (inclusive), a total of 108,896 preferred shares were bought back within the framework of the share buyback of ...
Drägerwerk AG & Co. KGaA
About the publication
27 October 2022 07:30AM
Drägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022
DE0005550602
Dräger expects faster sales recognition in the fourth quarter of 2022 Noticeable increase in order intake in the first nine months Net sales and earnings significantly below prior year, in particular due to disrupted supply chains Slight easing of supply situation in the third quarter Strong acceleration in sales recognition expected in fourth ...
Drägerwerk AG & Co. KGaA
About the publication
27 October 2022 07:30AM
Dräger expects faster sales recognition in the fourth quarter of 2022
DE0005550602
Dräger expects faster sales recognition in the fourth quarter of 2022 Noticeable increase in order intake in the first nine months Net sales and earnings significantly below prior year, in particular due to disrupted supply chains Slight easing of supply situation in the third quarter Strong acceleration in sales recognition expected in fourth ...
Drägerwerk AG & Co. KGaA
About the publication
14 October 2022 06:00PM
Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures for the third quarter of 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable Lübeck, October 14, 2022 – Dräger's net sales in the third quarter of 2022...
Drägerwerk AG & Co. KGaA
About the publication
14 October 2022 06:00PM
net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures for the third quarter of 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable Lübeck, October 14, 2022 – Dräger's net sales in the third quarter of 2022...
Drägerwerk AG & Co. KGaA
About the publication
29 September 2022 02:26PM
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
DE0005550602
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission On September 26, 2022, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back som...
Drägerwerk AG & Co. KGaA
About the publication
29 September 2022 02:26PM
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
DE0005550602
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission On September 26, 2022, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back som...
Drägerwerk AG & Co. KGaA
About the publication
28 July 2022 07:30AM
Dräger expects significant recovery in business development in the second half of 2022
DE0005550602
Dräger expects significant recovery in business development in the second half of 2022 Order intake in the first half of the year significantly above prior-year level and own expectations Significant decline in net sales and earnings as expected Full-year forecast confirmed Lübeck—Drägerwerk AG & Co. KGaA has increased its order intake in th...
Drägerwerk AG & Co. KGaA
About the publication
28 July 2022 07:30AM
Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022
DE0005550602
Dräger expects significant recovery in business development in the second half of 2022 Order intake in the first half of the year significantly above prior-year level and own expectations Significant decline in net sales and earnings as expected Full-year forecast confirmed Lübeck—Drägerwerk AG & Co. KGaA has increased its order intake in th...
Drägerwerk AG & Co. KGaA
About the publication
14 July 2022 08:58PM
Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior-year level despite strong order development – full-year guidance confirmed due to expected business recovery in the second half of the year Lübeck, July 14, 2022 – Dräger's net s...
Drägerwerk AG & Co. KGaA
About the publication
14 July 2022 08:58PM
net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2
DE0005550602
Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior-year level despite strong order development – full-year guidance confirmed due to expected business recovery in the second half of the year Lübeck, July 14, 2022 – Dräger's net s...
Drägerwerk AG & Co. KGaA
About the publication
More Drägerwerk AG & Co. KGaA related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 2 12th May 2022 Dräger, Stefan DD
Short Seller (DE) 8 12th July 2022 Sandbar Asset Management SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN